Physician profile
Anuj Singh
NPI 1528097490
$1,421.44
in general payments reported to CMS, 2019-2025
11 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $212 · 2021: $142 · 2023: $406 · 2024: $511 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,067.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $594.25 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Musculoskeletal Transplant Foundation INC. | $199.47 | 2020-2025 | |
| Convatec INC. | $161.32 | 2021-2025 | |
| Kerecis Limited | $125.79 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Stryker Corporation | $124.86 | 2023 | Prostep |
| Kci USA, INC. | $59.71 | 2021-2023 | Prevena, 3m Cavilon, V.A.C.Ulta |
| Solventum Corporation | $39.17 | 2025 | Activ.A.C., V.A.C. Veraflo Cleanse Choice, 3m Cavilon |
| Treace Medical Concepts, INC. | $38.82 | 2024 | |
| Smith+Nephew, INC. | $34.83 | 2020-2024 | Grafix Pl |
| Suvon Surgical LLC | $25.48 | 2024 | |
| Acell, INC. | $17.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anuj Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.